Case of Adrenocortical Cancer Eleven Years After Diagnosis of Adrenocortical Adenoma
- Authors: Lisitsyn A.A.1, Zemlianoy V.P.1, Mazurov V.I.1, Velikanova L.I.1, Bekhtereva I.A.1
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- Section: Clinical observations
- Submitted: 15.09.2025
- Accepted: 20.10.2025
- Published: 22.11.2025
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/690434
- DOI: https://doi.org/10.17816/KMJ690434
- EDN: https://elibrary.ru/EEACXM
- ID: 690434
Cite item
Abstract
High-resolution imaging has increased the detection rate of adrenal gland neoplasms, necessitating changes in the management of patients with adrenal incidentalomas. Despite existing guidelines, the treatment strategy in patients with incidental adrenal gland neoplasms of <4 cm remains debatable. According to the updated EHS/ENSAT guidelines on incidentalomas (2023), benign neoplasms with ≤10 HU do not require further imaging examinations. For neoplasms of <4 cm with a native density of 11–20 HU, a follow-up examination after 12 months is recommended. This paper presents a clinical case of adrenocortical cancer with autonomous cortisol secretion, which originated from a nonfunctioning right adrenal gland neoplasm of <2 cm. The tumor was detected accidentally during abdominal and retroperitoneal ultrasound and computed tomography; however, malignant transformation did not occur until 11 years later. A comprehensive preoperative assessment, including biochemical and imaging examinations, confirmed that the patient was eligible for elective surgery. A pathological examination confirmed an oncocytic adrenocortical carcinoma (Ki-67: 40%).
About the authors
Aleksandr A. Lisitsyn
North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: 9213244516@mail.ru
ORCID iD: 0000-0003-2045-0044
SPIN-code: 3237-4309
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, Saint PetersburgVyacheslav P. Zemlianoy
North-Western State Medical University named after I.I. Mechnikov
Email: zeml.spb@mail.ru
ORCID iD: 0000-0003-2329-0023
SPIN-code: 5398-3460
MD, Dr. Sci. (Medicine), Professor, Honored Doctor of the Russian Federation
Russian Federation, Saint PetersburgVadim I. Mazurov
North-Western State Medical University named after I.I. Mechnikov
Email: maz.nwgmu@yandex.ru
ORCID iD: 0000-0002-0797-2051
SPIN-code: 6823-5482
Scopus Author ID: 16936315400
MD, Dr. Sci. (Medicine), Professor, academician of the Russian Academy of Sciences, Honored Scientist of the Russian Federation
Russian Federation, Saint PetersburgLudmila I. Velikanova
North-Western State Medical University named after I.I. Mechnikov
Email: velikanova46@gmail.com
ORCID iD: 0000-0002-9352-4035
SPIN-code: 5586-4851
Dr. Sci. (Biology), Professor
Russian Federation, Saint PetersburgIrina A. Bekhtereva
North-Western State Medical University named after I.I. Mechnikov
Email: Irina.Bekhtereva@szgmu.ru
ORCID iD: 0000-0002-5206-3367
SPIN-code: 3954-2873
MD, Dr. Sci. (Medicine), Assistant Professor
Russian Federation, Saint PetersburgReferences
- Parry SN, Lau NS. A case of adrenal cortical carcinoma arising from a regularly monitored sub-centimetre adrenal incidentaloma. Endocrinol Diabetes Metab Case Rep. 2024;2024(1):23–0120. doi: 10.1530/EDM-23-0120 EDN: KVNBWT
- Thuzar M, Perry-Keene DA, d'Emden MC, Duncan EL. An adrenocortical carcinoma evolving from a small adrenal incidentaloma after years of latency. AACE Clin Case Rep. 2018;4(1):65–69. doi: 10.4158/EP171931.CR
- Angelousi A, Jouinot A, Bourgioti C, et al. Transformation of a Benign Adrenocortical Adenoma to a Metastatic Adrenocortical Carcinoma Is Rare But It Happens. JCEM Case Rep. 2024;2(8):luae131. doi: 10.1210/jcemcr/luae131 EDN: OFDWCJ
- Fassnacht M, Tsagarakis S, Terzolo M, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023;189:G1–42. doi: 10.1093/ejendo/lvad066 EDN: EZKFAO
- Kohli HS, Manthri S, Jain S, et al. An Adrenocortical Carcinoma Evolving After Nine Years of Latency From a Small Adrenal Incidentaloma. Cureus. 2021;13(8):e16851. doi: 10.7759/cureus.16851
- Aono D, Kometani M, Asano T, et al. A case of adrenocortical carcinoma diagnosed 9 years after the discovery of adrenal incidentaloma. Endocrine Journal. 2022;69(12):1415–1421. doi: 10.1507/endocrj.ej22-0171 EDN: ZCXCYQ
- Vogg N, Müller T, Floren A, et al. Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors. Clinica Chimica Acta. 2023;543:117301. doi: 10.1016/j.cca.2023.117301
- Bednarczuk T, Bolanowski M, Sworczak K, et al. Adrenal incidentaloma in adults: management recommendations by the Polish Society of Endocrinology. Endokrynol Pol. 2016;67:234–258. doi: 10.5603/EP.a2016.0039 EDN: XYVWRH
- Tabarin A, Bardet S, Bertherat J, et al. Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus. Ann Endocrinol. 2008;69:487–500. doi: 10.1016/j.ando.2008.09.003
- Zeiger MA, Thompson GB, Duh QY, et al. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract. 2009;15(Suppl 1):1–20. doi: 10.4158/EP.15.S1.1
- Elhassan YS, Alahdab F, Prete A, et al. Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis. Ann Intern Med. 2019;171:107–116. doi: 10.7326/M18-3630
- Reimondo G, Muller A, Ingargiola E, et al. Is Follow-up of Adrenal Incidentalomas Always Mandatory? Endocrinol Metab. 2020;35(1):26–35. doi: 10.3803/enm.2020.35.1.26 EDN: IIGCAV
- Heaton JH, Wood MA, Kim AC, et al. Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin. Am J Pathol. 2012;181:1017–1033. doi: 10.1016/j.ajpath.2012.05.026
- Bernard MH, Sidhu S, Berger N, et al. A case report in favor of a multistep adrenocortical tumorigenesis. J Clin Endocrinol Metab. 2003;88(3):998–1001. doi: 10.1210/jc.2002-021117
- Tang T, Zhang L, Li C, Zhou T. Gastric and adrenal metastasis from breast cancer: Case report and review of literature. Medicine. 2020;99(3):e18812. doi: 10.1097/MD.0000000000018812 EDN: JFYQYQ
- Sahdev A. Recommendations for the management of adrenal incidentalomas: what is pertinent for radiologists? Br J Radiol. 2017;90(1072):20160627. doi: 10.1259/bjr.20160627
- Hong AR, Kim JH, Park KS, et al. Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice. Eur J Endocrinol. 2017;177:475–483. doi: 10.1530/EJE-17-0372
- Lee JM, Kim MK, Ko SH, et al. Clinical Guidelines for the Management of Adrenal Incidentaloma. Endocrinol Metab. 2017;32(2):200–218. doi: 10.3803/EnM.2017.32.2.200
- WHO classification of tumours of endocrine organs. Lloyd RV, Osamura RY, Klöppel G, et al., editors. In: World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer (IARC); 2017. 355 p. ISBN: 9789283244936
- Coppola Bottazzi E, Gambardella C, Mongardini FM, et al. Prognosis of Adrenal Oncocytic Neoplasms (AONs): Literature Review of 287 Cases and Presentation of the Oldest Patient. J Clin Med. 2023;12(21):6925. doi: 10.3390/jcm12216925 EDN: ONNIVE
- Picut B, Dubuis JB, Demarchi MS, Fournier I. Atypical clinical presentation of oncocytic adrenocortical carcinoma with decompensated metabolic syndrome and psychotic outbreak. BMJ Case Rep. 2025;18(3):e262948. doi: 10.1136/bcr-2024-262948 EDN: SJCGRO
Supplementary files

